EA202192366A1 - CONDENSED TRICYCLIC COMPOUNDS USED AS ANTI-CANCER AGENTS - Google Patents

CONDENSED TRICYCLIC COMPOUNDS USED AS ANTI-CANCER AGENTS

Info

Publication number
EA202192366A1
EA202192366A1 EA202192366A EA202192366A EA202192366A1 EA 202192366 A1 EA202192366 A1 EA 202192366A1 EA 202192366 A EA202192366 A EA 202192366A EA 202192366 A EA202192366 A EA 202192366A EA 202192366 A1 EA202192366 A1 EA 202192366A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds used
cancer agents
tricyclic compounds
condensed tricyclic
present description
Prior art date
Application number
EA202192366A
Other languages
Russian (ru)
Inventor
Джейсон Грант Кеттл
Иэн Симпсон
Кристофер Филлипс
Скотт Бойд
Оливер Росс Стьюард
Майкл Стивен Боднарчук
Дойл Джозеф Кассар
Курт Гордон Пайк
Original Assignee
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астразенека Аб filed Critical Астразенека Аб
Priority claimed from PCT/EP2020/055551 external-priority patent/WO2020178282A1/en
Publication of EA202192366A1 publication Critical patent/EA202192366A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Настоящее описание относится к соединениям формулы (A)и их фармацевтически приемлемым солям. Настоящее описание также относится к способам и промежуточным соединениям, применяемым для их получения, фармацевтическим композициям, содержащим их, и к их применению в лечении нарушений, связанных с пролиферацией клеток.The present description relates to compounds of formula (A) and their pharmaceutically acceptable salts. The present description also relates to methods and intermediates used for their preparation, pharmaceutical compositions containing them, and their use in the treatment of disorders associated with cell proliferation.

EA202192366A 2019-12-20 2020-03-03 CONDENSED TRICYCLIC COMPOUNDS USED AS ANTI-CANCER AGENTS EA202192366A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962951146P 2019-12-20 2019-12-20
PCT/EP2020/055551 WO2020178282A1 (en) 2019-03-05 2020-03-03 Fused tricyclic compounds useful as anticancer agents

Publications (1)

Publication Number Publication Date
EA202192366A1 true EA202192366A1 (en) 2021-11-23

Family

ID=78768127

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192366A EA202192366A1 (en) 2019-12-20 2020-03-03 CONDENSED TRICYCLIC COMPOUNDS USED AS ANTI-CANCER AGENTS

Country Status (1)

Country Link
EA (1) EA202192366A1 (en)

Similar Documents

Publication Publication Date Title
PH12020551870A1 (en) Tetracyclic heteroaryl compounds
JOP20210241A1 (en) Fused tricyclic compounds useful as anticancer agents
NI201900039A (en) DERIVATIVES OF 6, 7, 8, 9-TETRAHIDRO-3H-PIRAZOLO [4, 3-F] ISOQUINOLINE USEFUL IN THE TREATMENT OF CANCER
EA201490300A1 (en) 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamide in the BTK-Inhibitor
EA201590453A1 (en) CONDENSED BICYCLIC DERIVATIVES OF SULFAMOIL AND THEIR APPLICATION AS A MEDICINE PREPARATION FOR THE TREATMENT OF HEPATITIS B
EA201370166A1 (en) CONTAINING DIRYLACETHYLENEHYDRAZIDE THYROZINKINASE INHIBITORS
EA201071040A1 (en) NEW DERIVATIVES 1-BENZYL-3-HYDROXYMETHYLINDASOL AND THEIR APPLICATION IN THE TREATMENT OF DISEASES CAUSED BY EXPRESSION OF MCP-1, CX3CR1 And P40
EA201591195A1 (en) NEW QUINOLON DERIVATIVES
EA201490471A1 (en) PYRIDAZINOUS COMPOUNDS AND THEIR APPLICATION AS DAAO INHIBITORS
EA201071039A1 (en) NEW DERIVATIVES 1-BENZYL-3-HYDROXYMETYLINDASOL AND THEIR APPLICATION FOR THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1 And P40
EA201590183A1 (en) AZAINDOL DERIVATIVES PERFORMING AS PI3K INHIBITORS
EA201600636A1 (en) 2-AMINO-6-METHYL-4,4A, 5,6-TETRAHYDROPYRANO [3,4-D] [1,3] TIASIN-8A (8H) -IL-1,3-TIAZOL-4-IL AMIDY
TN2020000009A1 (en) Estrogen receptor modulators
EA201491651A1 (en) NEW CONNECTIONS FOR THE TREATMENT OF DISLIPIDEMIA AND RELATED DISEASES
CO2024002844A2 (en) Spirocyclic compounds
BR112022012684A2 (en) CYCLIC COMPOUNDS AND METHODS OF THEIR USE
EA202192366A1 (en) CONDENSED TRICYCLIC COMPOUNDS USED AS ANTI-CANCER AGENTS
EA201792170A1 (en) INDOLA DERIVATIVES
EA202190966A1 (en) CGRP ANTAGONIST PRODrugs
EA202092600A1 (en) TETRACYCLIC HETEROARYL COMPOUNDS
EA202192111A1 (en) NEW TRITERPENE DERIVATIVES AS HIV INHIBITORS
EA201991734A1 (en) Estrogen Receptor Modulators
EA201990943A1 (en) 6,7,8,9-TETRAHYDRO-3H-PYRAZOLO [4,3-f] ISOCHINOLINE DERIVATIVES APPLICABLE IN TREATMENT OF CANCER
EA200802000A1 (en) PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS
EA202191103A1 (en) THERAPEUTIC CONNECTIONS